NASDAQ : RAPP

Rapport Therapeutics, Inc. Common Stock — Earnings Estimates

$40.98 USD

-$1.8 (-4.21%)

Volume
240.88K
Average Volume
367.63K
Market Capitalization
$1.96B
P/E Ratio
-15.76
Dividend Yield
0.00%
Price Target
$60.50
Year High
$44.28
Year Low
$13.62
Day High
—
Day Low
—
Payout Ratio
$0.00
Current Ratio
$27.08

Annual earnings financials

RAPP financial data with annual/quarterly toggle

RAPP GAAP EPS - Annual & Quarterly

RAPP Sales Revenue - Annual & Quarterly

RAPP Shares Outstanding - Annual & Quarterly

Hover over bars to see exact values. Data includes up to 12 years of annual financials and up to 20 quarters of quarterly data from FMP Financial Data.

RAPP Estimated and Actual Revenue by Quarter
RAPP Estimated and Actual EPS by Quarter
RAPP Analyst Forecasts — EBITDA & EBIT
Quarter Date No of Estimates Ebitda Ebit
Low High Average Low High Average
2028-12-31 2 - - - - - -
2028-09-30 1 - - - - - -
2028-06-30 1 - - - - - -
2028-03-31 2 - - - - - -
2027-12-31 3 - - - - - -
2027-09-30 2 - - - - - -
RAPP Analyst Forecasts — Net Income & SGA Expense
Quarter Date No of Estimates NetIncome SgaExpense
Low High Average Low High Average
2028-12-31 2 -38.04M -38.04M -38.04M - - -
2028-09-30 1 -37.47M -37.47M -37.47M - - -
2028-06-30 1 -38.07M -38.07M -38.07M - - -
2028-03-31 2 -37.98M -37.98M -37.98M - - -
2027-12-31 3 -54.79M -54.79M -54.79M - - -
2027-09-30 2 -53.43M -53.43M -53.43M - - -
RAPP Analyst Forecasts — Revenue & EPS
Quarter Date No of Revenue Estimates Revenue No of EPS Estimates EPS
Low High Average Low High Average
2028-12-31 2 20M 20M 20M 2 -0.8053 -0.8053 -0.8053
2028-09-30 1 20M 20M 20M 2 -0.7933 -0.7933 -0.7933
2028-06-30 1 20M 20M 20M 2 -0.806 -0.806 -0.806
2028-03-31 2 20M 20M 20M 2 -0.8041 -0.8041 -0.8041
2027-12-31 3 20M 20M 20M 1 -1.15982 -1.15982 -1.15982
2027-09-30 2 20M 20M 20M 1 -1.13118 -1.13118 -1.13118